Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients
Status:
Completed
Trial end date:
2016-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if the biomarker information obtained (learned or
received) from the earlier studies can tell us whether or not Taxotere and/or
Adriamycin/Cytoxan can cause tumors to become smaller.